Uniqure Total Stockholder Equity from 2010 to 2024

QURE Stock  USD 5.78  0.07  1.20%   
Check Uniqure NV financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Uniqure NV's main balance sheet or income statement drivers, such as , as well as many indicators such as . Uniqure financial statements analysis is a perfect complement when working with Uniqure NV Valuation or Volatility modules.
  
Check out the analysis of Uniqure NV Correlation against competitors.
For information on how to trade Uniqure Stock refer to our How to Trade Uniqure Stock guide.

About Uniqure NV Financial Statements

Uniqure NV stakeholders use historical fundamental indicators, such as Uniqure NV's Total Stockholder Equity, to determine how well the company is positioned to perform in the future. Although Uniqure NV investors may analyze each financial statement separately, they are all interrelated. For example, changes in Uniqure NV's assets and liabilities are reflected in the revenues and expenses on Uniqure NV's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Uniqure NV. Please read more on our technical analysis and fundamental analysis pages.
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. The company also engages in developing AMT-130, a gene therapy that is in Phase III clinical study for the treatment of Huntingtons disease AMT-060, which is in Phase III clinical trial for the treatment of hemophilia B AMT-210, a product candidate for the treatment of Parkinsons disease AMT-260 for temporal lobe epilepsy AMT-240, a preclinical product candidate for the treatment of autosomal dominant Alzheimers disease and AMT-161 for the treatment of amyotrophic lateral sclerosis. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands. Uniqure NV is traded on NASDAQ Exchange in the United States.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Uniqure NV is a strong investment it is important to analyze Uniqure NV's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Uniqure NV's future performance. For an informed investment choice regarding Uniqure Stock, refer to the following important reports:
Check out the analysis of Uniqure NV Correlation against competitors.
For information on how to trade Uniqure Stock refer to our How to Trade Uniqure Stock guide.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Uniqure NV. If investors know Uniqure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Uniqure NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Uniqure NV is measured differently than its book value, which is the value of Uniqure that is recorded on the company's balance sheet. Investors also form their own opinion of Uniqure NV's value that differs from its market value or its book value, called intrinsic value, which is Uniqure NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Uniqure NV's market value can be influenced by many factors that don't directly affect Uniqure NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Uniqure NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Uniqure NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Uniqure NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.